HAPPE Spine received a second round of financing, again with participation from Genesis Innovation Group with investments from cultivate(MD) Capital Funds I and II.
The company is developing a material technology that allows PEEK to be both porous and bioactive, osteointegrative and radiolucent. Proprietary molding methods support the manufacture of material with fully interconnected porosity, including hydroxyapatite whisker exposure throughout to promote bony ingrowth onto and within an implant. A unique manufacturing method can vary the implant density or porosity to optimize osteointegration and bio-mechanical loading.
HAPPE Spine plans to submit a cervical implant for FDA clearance during 2019.
HAPPE Spine received a second round of financing, again with participation from Genesis Innovation Group with investments from cultivate(MD) Capital Funds I and II.
The company is developing a material technology that allows PEEK to be both porous and bioactive, osteointegrative and radiolucent. Proprietary molding methods support the...
HAPPE Spine received a second round of financing, again with participation from Genesis Innovation Group with investments from cultivate(MD) Capital Funds I and II.
The company is developing a material technology that allows PEEK to be both porous and bioactive, osteointegrative and radiolucent. Proprietary molding methods support the manufacture of material with fully interconnected porosity, including hydroxyapatite whisker exposure throughout to promote bony ingrowth onto and within an implant. A unique manufacturing method can vary the implant density or porosity to optimize osteointegration and bio-mechanical loading.
HAPPE Spine plans to submit a cervical implant for FDA clearance during 2019.
Copy to clipboard 
